CRYOCRATE LLC
Biotech · Private
OdinSol®, a biocompatible cryopreservation medium that enables long-term storage of cells and tissues without toxic cryoprotectants
cryocrate.com →- Grants
- $9.3M
- 16 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 1
- 0 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues | $152,619 | |
| Federal grant | Department of Health and Human Services · Phase I · An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues | $152,619 | |
| Federal grant | Department of Agriculture · A Highly Efficient Vitrification Device For Animal Embryos And Spermatozoa | $99,686 | |
| Federal grant | Department of Health and Human Services · Phase I · In-Situ Cryopreservation Without Cryoprotectants | $291,523 | |
| Federal grant | Department of Health and Human Services · Phase II · An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues | $815,083 | |
| Federal grant | Department of Health and Human Services · Phase I · A Novel Cryopreservation Technology for Large Skin Grafts to Facilitate Tissue Banking and Allograft Transplantations | $160,371 | |
| Federal grant | Department of Health and Human Services · Phase II · An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues | $313,256 | |
| Federal grant | Department of Health and Human Services · Phase II · An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues | $751,085 | |
| Federal grant | Department of Health and Human Services · Phase II · Late-stage Preclinical Development and cGMP Production of a First-in-Class Cornea Cryopreservation Kit Based on FDA Feedback | $753,985 | |
| Federal grant | Department of Health and Human Services · Phase II · Innovation of Skin Banking and Transplantation Based on a First-in-Class Biocompatible Cryopreservation Technology | $751,525 | |
| Federal grant | Department of Health and Human Services · Phase II · Late-stage Preclinical Development and cGMP Production of a First-in-Class Cornea Cryopreservation Kit Based on FDA Feedback | $726,985 | |
| Federal grant | Department of Health and Human Services · Phase II · Innovation of Biobanking for Cellular Adoptive Immunotherapies Based on a First-in-Class Biocompatible Cryopreservation Technology for T and NK Cells and Their CAR-Engineered Products | $898,913 | |
| Federal grant | Department of Health and Human Services · Phase II · Innovation of Skin Banking and Transplantation Based on a First-in-Class Biocompatible Cryopreservation Technology | $736,276 | |
| Federal grant | Department of Health and Human Services · Phase II · Innovation of Biobanking for Cellular Adoptive Immunotherapies Based on a First-in-Class Biocompatible Cryopreservation Technology for T and NK Cells and Their CAR-Engineered Products | $864,173 | |
| Federal grant | Department of Health and Human Services · Phase II · Establishment of a First-in-Class Biocompatible and Efficient Cryopreservation Technology Platform for the Next Generation of Cell-Based Therapeutics in Regenerative Medicine and Drug Discovery | $940,821 | |
| Federal grant | Department of Health and Human Services · Phase II · Establishment of a First-in-Class Biocompatible and Efficient Cryopreservation Technology Platform for the Next Generation of Cell-Based Therapeutics in Regenerative Medicine and Drug Discovery | $922,420 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1402 | MYOFINITY BIOSCIENCES INC | — | — |
| 1403 | PANACISE BIO, INC. | — | — |
| 1404 | On Target Therapeutics, LLC | — | — |
| 1405 | CRYOCRATE LLC | — | — |
| 1406 | DD Therapeutics, LLC | — | — |
| 1407 | Bedrock Therapeutics, Inc. | — | — |
| 1408 | Integrated Protein Technologies, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Efficient Cryopreservation Medium That Preserves Tissue Ultra-structures And Eliminates Tissue Cellsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.